Research ArticleClinical Studies
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients
ANDREA PANUNZIO, STEFANO TAPPERO, CRISTINA CANO GARCIA, MATTIA PICCINELLI, FRANCESCO BARLETTA, REHA-BARIS INCESU, ZHE TIAN, ALESSANDRO TAFURI, DERYA TILKI, ALBERTO BRIGANTI, OTTAVIO DE COBELLI, FELIX K.H. CHUN, CARLO TERRONE, FRED SAAD, SHAHROKH F. SHARIAT, ISABELLE BOURDEAU, MARIA ANGELA CERRUTO, ALESSANDRO ANTONELLI and PIERRE I. KARAKIEWICZ
Anticancer Research November 2022, 42 (11) 5579-5585; DOI: https://doi.org/10.21873/anticanres.16065
ANDREA PANUNZIO
1Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy;
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
STEFANO TAPPERO
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
3Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genoa, Italy;
4Department of Urology, IRCCS Policlinico San Martino, Genoa, Italy;
CRISTINA CANO GARCIA
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
5Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany;
MATTIA PICCINELLI
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
6Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy;
FRANCESCO BARLETTA
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
7Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy;
REHA-BARIS INCESU
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
8Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany;
ZHE TIAN
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
ALESSANDRO TAFURI
1Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy;
DERYA TILKI
8Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany;
9Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany;
10Department of Urology, Koc University Hospital, Istanbul, Turkey;
ALBERTO BRIGANTI
7Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy;
OTTAVIO DE COBELLI
6Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy;
FELIX K.H. CHUN
5Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany;
CARLO TERRONE
3Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genoa, Italy;
4Department of Urology, IRCCS Policlinico San Martino, Genoa, Italy;
FRED SAAD
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
SHAHROKH F. SHARIAT
11Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;
12Department of Urology, Weill Cornell Medical College, New York, NY, U.S.A.;
13Department of Urology, University of Texas Southwestern, Dallas, TX, U.S.A.;
14Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan;
ISABELLE BOURDEAU
15Division of Endocrinology, Department of Medicine and Research Center, Centre Hospitalier de l’Université de Montreal (CHUM), Montreal, QC, Canada
MARIA ANGELA CERRUTO
1Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy;
ALESSANDRO ANTONELLI
1Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy;
PIERRE I. KARAKIEWICZ
2Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada;
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients
ANDREA PANUNZIO, STEFANO TAPPERO, CRISTINA CANO GARCIA, MATTIA PICCINELLI, FRANCESCO BARLETTA, REHA-BARIS INCESU, ZHE TIAN, ALESSANDRO TAFURI, DERYA TILKI, ALBERTO BRIGANTI, OTTAVIO DE COBELLI, FELIX K.H. CHUN, CARLO TERRONE, FRED SAAD, SHAHROKH F. SHARIAT, ISABELLE BOURDEAU, MARIA ANGELA CERRUTO, ALESSANDRO ANTONELLI, PIERRE I. KARAKIEWICZ
Anticancer Research Nov 2022, 42 (11) 5579-5585; DOI: 10.21873/anticanres.16065
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients
ANDREA PANUNZIO, STEFANO TAPPERO, CRISTINA CANO GARCIA, MATTIA PICCINELLI, FRANCESCO BARLETTA, REHA-BARIS INCESU, ZHE TIAN, ALESSANDRO TAFURI, DERYA TILKI, ALBERTO BRIGANTI, OTTAVIO DE COBELLI, FELIX K.H. CHUN, CARLO TERRONE, FRED SAAD, SHAHROKH F. SHARIAT, ISABELLE BOURDEAU, MARIA ANGELA CERRUTO, ALESSANDRO ANTONELLI, PIERRE I. KARAKIEWICZ
Anticancer Research Nov 2022, 42 (11) 5579-5585; DOI: 10.21873/anticanres.16065
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.